Bonus Episode: Vitiligo Is an Immune Mediated Disease – Do We Have the Right Approach and Tools to Manage? – Part 1
This two-part podcast series delves into vitiligo as a systemic disease, its known risk factors, and the stigma often associated with the condition.
Featuring experts Amit G. Pandya, University of Texas Southwestern Medical Centre, Dallas, USA, and Thierry Passeron, Université Côte d’Azur, Nice, France, this podcast series also discusses the goals to consider in the management of patients with vitiligo, and the levels of patient satisfaction associated with current treatment options.
This podcast was funded by AbbVie. The content of the podcast reflects the opinions of the speakers and does not necessarily reflect the views of AbbVie.
Additional insights on living with vitiligo are available in an informative infographic, ‘The Unmet Need for Patients with Vitiligo is High’, which gives an overview of the condition’s symptoms and their impact, whilst also highlighting the comorbidities and management gaps that patients with vitiligo may experience.
You Might Like
